Leading the way to a cure


In Vivo Validation And Characterization Of Allelic Variants In Lupus

Means, Terry K. Ph.D.

Massachusetts General Hospital

Genome-wide association studies such as the SLE Genetics consortium have identified numerous genetic variants associated with an increased risk of lupus. However, a major barrier in lupus research is the lack of a rapid high-throughput system, a special kind of technology that can validate these candidate variants and determine if they truly do contribute to lupus.

Dr. Means and his team have developed and optimized a novel approach to express human, lupus-related genes in animal models. This approach can rapidly generate animal models that harbor an immune system developed with cells that express human genetic mutations. 

With this grant, the team will use their animal models to study the effects of human lupus-related risk genes on the development and progression of lupus. 

What this study means for people with lupus: These studies will provide a rich pipeline of molecular targets that could be fast-tracked for the development of lupus-related treatments.

1.5 million

people in the U.S. have Lupus.

172 million

dollars committed to lupus research by the Lupus Research Alliance.

We're walking across the United States to raise awareness and funds for lupus research.


Show your support by visiting the Lupus Research Alliance online store. Discover the perfect gift, or prepare for a walk with our selection of apparel and accessories.

Powered by Blackbaud
nonprofit software